A Metabolomics Approach to Profile Novel Chemical Markers for Identification and Authentification of Terminalia Species

Similar documents
INTRODUCTION CH 3 CH CH 3 3. C 37 H 48 N 6 O 5 S 2, molecular weight Figure 1. The Xevo QTof MS System.

Rapid Analysis of Water-Soluble Vitamins in Infant Formula by Standard-Addition

Applying a Novel Glycan Tagging Reagent, RapiFluor-MS, and an Integrated UPLC-FLR/QTof MS System for Low Abundant N-Glycan Analysis

Matrix Factor Determination with the Waters Regulated Bioanalysis System Solution

UPLC-MS/MS Analysis of Azole Antifungals in Serum for Clinical Research

A UPLC/MS Approach for the Diagnosis of Inborn Errors of Metabolism

UPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes

Rapid, Simple Impurity Characterization with the Xevo TQ Mass Spectrometer

[ APPLICATION NOTE ] APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

Rapid Lipid Profiling of Serum by Reverse Phase UPLC-Tandem Quadrupole MS

The Application of UPLC/MS E for the Analysis of Bile Acids in Biological Fluids

Analysis of Testosterone, Androstenedione, and Dehydroepiandrosterone Sulfate in Serum for Clinical Research

CHARACTERIZATION AND DETECTION OF OLIVE OIL ADULTERATIONS USING CHEMOMETRICS

Profiling Flavonoid Isomers in Highly Complex Citrus Juice Samples Using UPLC Ion Mobility Time-of-Flight Mass Spectrometry

[ APPLICATION NOTE ] High Sensitivity Intact Monoclonal Antibody (mab) HRMS Quantification APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

O O H. Robert S. Plumb and Paul D. Rainville Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL. LC /MS conditions

Analysis of the Non-Ionic Surfactant Triton-X Using UltraPerformance Convergence Chromatography (UPC 2 ) with MS and UV Detection

[ APPLICATION NOTE ] Profiling Mono and Disaccharides in Milk and Infant Formula Using the ACQUITY Arc System and ACQUITY QDa Detector

A High Sensitivity UPLC/MS/MS Method for the Analysis of Clopidogrel and Clopidogrel Carboxylic Acid Metabolite in Human K 2 EDTA Plasma

Profiling and Quantitation of Metabolomic Signatures for Breast Cancer Cell Progression

John Haselden 1, Gordon Dear 1, Jennifer H. Granger 2, and Robert S. Plumb 2. 1GlaxoSmithKline, Ware, UK; 2 Waters Corporation, Milford, MA, USA

[ APPLICATION NOTE ] Oasis PRiME HLB Cartridge for Cleanup of Infant Formula Extracts Prior to UPLC-MS/MS Multiresidue Veterinary Drugs Analysis

A Definitive Lipidomics Workflow for Human Plasma Utilizing Off-line Enrichment and Class Specific Separation of Phospholipids

Analysis of Rosuvastatin in Dried Blood Spot and Plasma Using ACQUITY UPLC with 2D Technology

Analysis of Food Sugars in Various Matrices Using UPLC with Refractive Index (RI) Detection

A NOVEL METHOD OF M/Z DRIFT CORRECTION FOR OA-TOF MASS SPECTROMETERS BASED ON CONSTRUCTION OF LIBRARIES OF MATRIX COMPONENTS.

Analysis of N-Linked Glycans from Coagulation Factor IX, Recombinant and Plasma Derived, Using HILIC UPLC/FLR/QTof MS

Removal of Triton X-100 from Plasma Samples Using Mixed-Mode Solid Phase Extraction (SPE)

USP Method Transfer of Ziprasidone HCl from HPLC to UPLC

Providing a Universal, One-step Alternative to Liquid-Liquid Extraction in Bioanalysis

Jose Castro-Perez, Henry Shion, Kate Yu, John Shockcor, Emma Marsden-Edwards, Jeff Goshawk Waters Corporation, Milford, MA, U.S. and Manchester, UK

ApplicationNOTE EXACT MASS MEASUREMENT OF ACTIVE COMPONENTS OF TRADITIONAL HERBAL MEDICINES BY ORTHOGONAL ACCELERATION TIME-OF-FLIGHT.

Meeting Challenging Requirements for the Quantitation of Regulated Growth Promoters Dexamethasone and Betamethasone in Liver and Milk

Rapid Analysis of Bisphenols A, B, and E in Baby Food and Infant Formula Using ACQUITY UPLC with the Xevo TQD

Fast Separation of Triacylglycerols in Oils using UltraPerformance Convergence Chromatography (UPC 2 )

[ APPLICATION NOTE ] UPLC-MS/MS Analysis of 45 Amino Acids Using the Kairos Amino Acid Kit for Biomedical Research INTRODUCTION APPLICATION BENEFITS

Chemical Analysis Business Operations Waters Corporation Milford MA

Development and Validation of Improved RP-HPLC method for Identification and Estimation of Ellagic and Gallic acid in Triphala churna

A RAPID AND SENSITIVE UPLC/UV/MS METHOD FOR SIMVASTATIN AND LOVA S TAT IN IN SU P P O RT O F C L E A NING VA L I DAT IO N S T U DIES

Method Development for the Analysis of Endogenous Steroids Using Convergence Chromatography with Mass Spectrometric Detection

Rapid and Accurate LC-MS/MS Analysis of Nicotine and Related Compounds in Urine Using Raptor Biphenyl LC Columns and MS-Friendly Mobile Phases

Comparison of a UPLC Method across Multiple UHPLC Systems

Identification of Ginsenosides Using the SCIEX X500R QTOF System

A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS

Lipidomic Analysis by UPLC-QTOF MS

Determination of 6-Chloropicolinic Acid (6-CPA) in Crops by Liquid Chromatography with Tandem Mass Spectrometry Detection. EPL-BAS Method No.

Rapid Quantitative Analysis of Cannabidiol from Consumer Products Using UltraPerformance Convergence Chromatography

[ application note note ] ]

Neosolaniol. [Methods listed in the Feed Analysis Standards]

Rapid Screening and Quantitation of Postharvest Fungicides on Citrus Fruits Using AxION DSA/TOF and Flexar SQ MS

Probing for Packaging Migrants in a Pharmaceutical Impurities Assay Using UHPLC with UV and Mass Detection INTRODUCTION

Low-level environmental phthalate exposure associates with urine metabolome. alteration in a Chinese male cohort

Quantification of Budesonide Using UPLC and Xevo TQ-S

Reducing Sample Volume and Increasing Sensitivity for the Quantification of Human Insulin and 5 Analogs in Human Plasma Using ionkey/ms

Dienes Derivatization MaxSpec Kit

Extraction of Aflatoxin M1 From Infant Formula Using ISOLUTE Myco SPE Columns prior to LC-MS/MS Analysis

Automated Lipid Identification Using UPLC/HDMS E in Combination with SimLipid

Supplementary Information

Challenges in Developing an Ultra-Sensitive Bioanalytical Method for Ethinylestradiol in Human Plasma

Supporting Information

[APPLICATION NOTE] DETERMINATION OF AMINO ACIDS IN BEERS USING THE UPLC AMINO ACID ANALYSIS SOLUTION

Sample Preparation is Key

Data Independent MALDI Imaging HDMS E for Visualization and Identification of Lipids Directly from a Single Tissue Section

Uptake and Metabolism of Phthalate Esters by Edible Plants

A RAPID AND SENSITIVE ANALYSIS METHOD OF SUDAN RED I, II, III & IV IN TOMATO SAUCE USING ULTRA PERFORMANCE LC MS/MS

An Untargeted Exposure Study of Small Isolated Populations Using Atmospheric Gas Chromatography Coupled with High Resolution Mass Spectrometry

Development of a High Sensitivity SPE-LC-MS/MS Assay for the Quantification of Glucagon in Human Plasma Using the ionkey/ms System

Life Science and Chemical Analysis Solutions. Baljit Ubhi, Jeff Patrick, David Alonso, and Joe Shambaugh 1 2 3

A Robustness Study for the Agilent 6470 LC-MS/MS Mass Spectrometer

Analysis of Cannabinoids in Cannabis by UHPLC Using PDA Detection

GlycoWorks Sample Preparation Consumables

International Journal of Science and Research (IJSR) ISSN (Online): Index Copernicus Value (2013): 6.14 Impact Factor (2015): 6.

[ APPLICATION NOTE ] The Separation of 8 -THC, 9 -THC, and Their Enantiomers by UPC 2 Using Trefoil Chiral Columns INTRODUCTION APPLICATION BENEFITS

Detection of Cotinine and 3- hydroxycotine in Smokers Urine

SUPPLEMENTARY INFORMATION

Lipid Class Separation Using UPC 2 /MS

SULTANA SHAIKH, VANDANA JAIN *

ApplicationNOTE A MULTI-RESIDUE LC/MS/MS METHOD FOR THE DETERMINATION OF 81 PESTICIDE RESIDUES IN FRUIT AND VEGETABLES: PART 1, METHOD OVERVIEW

ASSAY AND IMPURITY METHOD FOR DURACOR TABLETS BY HPLC

LC-Based Lipidomics Analysis on QTRAP Instruments

Extraction of Multiple Mycotoxins From Nuts Using ISOLUTE Myco prior to LC-MS/MS Analysis

Determination of Amantadine Residues in Chicken by LCMS-8040

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

Quantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate Mass AxION 2 TOF Mass Spectrometer

Enhanced LC-MS Sensitivity of Vitamin D Assay by Selection of Appropriate Mobile Phase

Development and validation of a RP-HPLC method for the simultaneous determination of Embelin, Rottlerin and Ellagic acid in Vidangadi churna

Direct Analysis of Urinary Opioids and Metabolites by Mixed-Mode µelution SPE Combined with UPLC/MS/MS for Forensic Toxicology

Jody Dunstan, 1 Antonietta Gledhill, 1 Ailsa Hall, 2 Patrick Miller, 2 Christian Ramp 3. Waters Corporation, Manchester, UK 2

Simultaneous Analysis of Intact Human Insulin and Five Analogs in Human Plasma Using μelution SPE and a CORTECS UPLC Column

SEPARATION OF BRANCHED PFOS ISOMERS BY UPLC WITH MS/MS DETECTION

Latest Innovations in LC/MS/MS from Waters for Metabolism and Bioanalytical Applications

Quantitative Analysis of Underivatized Amino Acids in Plant Matrix by Hydrophilic Interaction Chromatography (HILIC) with LC/MS Detection

UPLC/MS/MS Method for the Routine Quantification of Regulated and Non-Regulated Lipophilic Marine Biotoxins in Shellfish

RP-HPLC Analysis of Temozolomide in Pharmaceutical Dosage Forms

Application Note. Author. Abstract. Introduction. Food Safety

Quantitative Analysis of -Hydroxybutyrate in Hair Using Target Analyte Finding Processing of Comprehensive GC-HRT Data

Rebaudioside a From Multiple Gene Donors Expressed in Yarrowia Lipolytica

PosterREPRINT RAPID, SELECTIVE SCREENING OF URINE SAMPLES FOR GLUCURONIDES BY LC/MS/MS INTRODUCTION ABSTRACT

The setup and validation of an LC-MS/MS assay of Androstenedione & Testosterone a labs experience

ACQUITY UPLC WITH PDA DETECTION: DETERMINING THE SENSITIVITY LIMITS OF OXYBUTYNIN AND RELATED COMPOUNDS

Transcription:

A Metabolomics Approach to Profile Novel Chemical Markers for Identification and Authentification of Terminalia Species Bharathi Avula, 1 Kate Yu, 2 Yan-Hong Wang, 1 Jordan Blodgett, 2 Alan Millar, 2 and Ikhlas A. Khan 1,3,4 1. National Center for Natural Products Research, School of Pharmacy, University of Mississippi, MS, U.S. 2. Waters Corporation, Milford, MA, U.S. 3. Department of Pharmacognosy, School of Pharmacy, University of Mississippi, MS, U.S. 4. Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia A P P L I C AT ION B E N E F I T S First metabolomics approach for a comprehensive chemical profiling of the Terminalia species using UPLC /TOF MS E, coupled with Multivariate statistical analysis (MSA), and applying the same approach to authenticate a popular Ayruveda medicine, Triphala. INTRODUCTION Terminalia is a genus of large trees of the flowering plant family Combretaceae, which is comprised of around 100 species that are distributed in tropical regions around the world. 1 Figure 1 shows the different Terminalia species that were included in this experiment. The fruits and bark from various Terminalia species have been used in Traditional Indian Medicine since ancient times for the treatment of various ailments. Some species have been used in Ayurvedic formulations, in either a single herb formulation, or in multiple herbal formulations. 2 Terminalia species provide rich sources of secondary metabolites, including cyclic triterpenes and their derivatives, flavonoids, tannins, and phenolic acids. 3 The exact chemical classes and levels may vary in different Terminalia species, which may contribute to the different biological activities observed. Yet mixtures of multiple species of Terminalia show other health benefits versus their individual effects. The Ayruveda medicine triphala is a perfect example of such a case. Waters solutions ACQUITY UPLC System Xevo G2 QTof Mass Spectrometer MarkerLynx XS Application Manager To date, Thin Layer Chromatography (TLC) is the common QC method used for analysis of triphala, and gallic acid and ellagic acid are used as the marker standards. However, gallic acid and ellagic acids are present in a majority of the Terminalia species, including the three fruits used in triphala, making them less than ideal for use as markers for authentication of triphala. It is important to have a suitable analytical method to distinguish individual herbs that will allow adequate quality control (QC) of raw materials and standardization of finished products. MassFragment Application Manager key words UPLC, QTof MS E, Multivariate Statistical Analysis, plant metabolomics, plant species authentication, Terminalia, Traditional Medicine, Ayruveda medicine, triphala 1

E X P E R IM E N TA L UPLC conditions LC system: ACQUITY UPLC Column: ACQUITY UPLC HSS T3 2.1 x 100 mm, 1.8 µm Column temp.: 60 C Flow rate: 500 µl/min. Mobile phase: A: water + 0.1% formic acid B: methanol Injection volume: 5 ml Sample preparation In order to perform the determinations for commercial products, five capsules were weighed and opened, and the contents were emptied. The content of capsules were mixed and triturated using a mortar and pestle. Dry plant samples (0.5 g), or an adequate amount of capsule/powder content, were weighed (about 500 mg) and sonicated in 2.5 ml of ethanol for 30 min, followed by centrifugation for 15 min at 4000 rpm. The supernatant was transferred to a 10-mL volumetric flask. The procedure was repeated three times, and the respective supernatants were combined. The final volume was adjusted to 10 ml with ethanol and mixed thoroughly. Prior to injection, an adequate volume (ca. 2 ml) was passed through a 0.2 µm nylon membrane filter. The first 1.0 ml was discarded and the remaining volume was collected in an LC sample vial. Each sample solution was injected in triplicate. Gradient: Total cycle time: MS conditions MS system: Ionization mode: 80% A to 40% A for 29 min., then step to 0% A and hold for 3 min. before re-equilibration 35 min. Xevo G2 QTof Mass Spectrometer ESI and ESI+ RESULTS AND DISCUSSION The UPLC/oaTOF MS E /MSA was performed for a total of 15 samples, as shown in Table 1. The key separation factors were the resolution and the peak capacity. Methanol was chosen over acetonitrile as it appeared to better retain peaks. Figure 2 shows the Base Peak Ion (BPI) chromatogram comparison for the five different herbal extracts, plus the two commercial products. The differences of these samples are shown in Figure 1. Acquisition range: 50 to 1200 m/z Capillary voltage: 3 kv Cone voltage: 30 V Desolvation temp.: 500 C Desolvation gas: 900 L/Hr Source temp.: 120 C CE: Low: 4 ev High: 45 to 60 ev The UPLC/oaTOF MS E analysis was performed for multiple Terminalia samples, shown in Table 1 in both positive and negative ionization modes. In this study, the results obtained in negative ionization mode were the main focus. To ensure data integrity, all samples were pooled into a single vial and used in the QC run. For each individual sample, six replicates of injection were performed with the sequence of the injections randomized. NCNPR Accession # Name Place 7523 Terminalia chebula CRISM, INDIA 7786 Terminalia chebula CHINA 7787 Terminalia chebula CHINA 8207 Terminalia arjuna CRISM, INDIA 4995 Terminalia arjuna INDIA 1229 Terminalia arjuna INDIA 7504 Terminalia bellerica CRISM, INDIA 4992 Terminalia bellerica CRISM, INDIA 4993 Terminalia bellerica CRISM, INDIA 2518 Emblica officinalis HAMDARD UNIVERSITY, PAKISTAN 7795 Emblica officinalis COMMERCIAL 4923 Emblica officinalis CRISM, INDIA 1356 Terminalia species COMMERCIAL Product-1 Product-2 Table 1. List of the 15 samples analyzed for this experiment. Dosage Form: Capsules Dosage Form: Powders 2

T. chebula E. officinalis http://protekherbals.com/emblica_officinalis http://www.artslant.com/ny/works/show/323770 T. arjuna http://www.immaginidalmondo.net/flora/terminalia-arjuna.jpg T. bellerica http://www.helpfulhealthtips.com/wp-content/uploads/2010/06/terminalia-belerica4.jpg Figure 1. E. officinalis and Terminalia species that were included in this work. A: Terminalia chebula E: Terminalia species B: Terminalia arjuna F: Porduct-1 C: Terminalia bellerica G: Product-2 D: Emblica officinalis G F E D C B A Figure 2. BPI comparison of the different species, plus two commercial Terminalia products. 3

A multivariate statistical analysis tool was used to obtain the comprehensive chemical profile of the samples. For multi-sample group analysis, Principle Component Analysis (PCA) is an effective tool. When performing MSA analysis, each sample group needs to be injected no less than three times to ensure the statistical validity (N=6 for this analysis); and a QC sample must be prepared for the system suitability test. In this study, all 15 samples were pooled into a single sample and used as the QC sample. Figure 3 shows the PCA scores plot for the entire dataset. There is a clear grouping pattern among different species of the herb. All old samples (collected and stored for more than two years), showed clear differences from the fresh samples. These differences seem to be more significant than the differences caused by various plant locations. The Terminalia species showed a closer similarity to Terminalia chebula than to Terminalia bellerica and Terminalia arjuna. Embelica officinalis was significantly different from all of the Terminalia spp, which was somewhat expected. The tightness of all of the QC injections provided a good sign of the system stability. T. chebula Terminalia species P-2 P-1 StdMix 9 Old Old Old T. bellerica QC Old T. arjuna E. officinalis Figure 3. The PCA scores plot for the entire sample set including the QC. 4

Figure 4 shows the loadings plot that correlates to the scores plot from the same PCA analysis, which highlights the key markers exact mass retention time (RT) pairs that have the most significant contributions for the sample grouping. The geographic distribution of the markers from the loadings plot correlated to the geographic distribution of the sample groups on the scores plot shown in Figure 3. For example, the two markers highlighted in Figure 4 are closely related to the sample groups T. arjuna and the StdMix-9. Hence, the markers in this region were expected to be higher in content in these two groups of samples. And the markers in the similar location were expected to have similar trending plots. Figure 4. PCA loadings plot of the entire Terminalia data set. 5

Figure 5 shows the trending plot for the two markers shown in Figure 4. The trends of these two markers are identical from sample to sample. As expected, they were high in T. arjuna and in StdMix9. The StdMix-9 is a mixture of nine markers that were known from previous studies. As it is standard in pure solvents, it is not surprising to see these two markers were very high in content. These two markers were also high in T. chebula. However, there are other markers more dominating in T. chebula. This finding provides an explanation as to why the markers were relatively distant from the T. arjuna group from the PCA scores plot. A:13.4363_695.4001, C 37 H 59 O 11, [M-H+H 2 CO 2 ] - B:10.83_711.3942, C 37 H 59 O 13, Arjunglucoside-I StdMix9 T. chebula T. arjuna India India A QC China China T. catappa P-1 P-2 B CRISM, India India T. bellerica E. officinalis Figure 5. Trend plot of the two key markers labeled from the PCA loadings plot shown in Figure 4. Also observed from the Trend plot was the fact that these two markers were significantly higher in content in the samples that were harvested in India. Using T. chebula as an example, the contents of these two markers were significantly higher in the India sample than the two samples from China, which suggests that plant location has a more profound influence in chemical content. 6

Terminalia is also a popular herb in Traditional Indian Medicine. For example, the Ayurveda medicine, triphala is a remedy that calls for the mixing of T. chebula, T. bellerica, and Emblica officinalis in equal portions. The authentication of triphala can become a challenge. The two commercial products (P-1 and P-2) in our sample set for this project are indeed the triphala extract. Figure 6 shows the PCA scores plot of the two products, plus the other herbs that the formula calls for: T. chebula, T. bellerica, and Emblica officinalis. T. bellerica P-2 T. chebula E. officinalis P-1 Figure 6. PCA scores plot of the two commercial Triphala products and the three herbs called for by the Triphala formula. The two products are positioned close to the center of the triangle seemingly formed by the three herbs, T. bellerica, T. chebula, and Emblica officinalis. This suggests that the two commercial products are highly likely to be an equally portioned mix of these three herbs. In future experiements we plan to prepare a solution by mixing the three herbs in equal portion, and performing the UPLC/oaTOF MS E /MSA, analysis workflow in the hopes that the PCA scores plot will show a correlation of this mixture with the P-1 and P-2 commercial products. 7

CONCLUSIONS The UPLC/oaTOF MS E /multivariate statistical analysis workflow offers an effective approach to obtain answers for complex samples in a complicated sample set. PCA analysis shows that the chemical content of Terminalia differs from species to species. Within the same species, plant location and collection time also affects the chemical content. Chemical identities of key markers can be obtained from PCA loadings plot. References: 1. Kirtikar KR et al. Indian Medicinal Plants Oriental Enterprises, 2nd edn. Uttranchal, India, 2001, 5, 1415-1439. 2. Ahmad I, Mehmood Z, Mohammad F. Screening of some Indian medicinal plants for their antimicrobial properties. J Ethnopharmacol. 1998, 62:183-193. Chattopadhyay RR and Bhattacharyya SK. 3. Terminalia chebula: An update. Pharmacog Rev 2007, 1:151-156. The two commercial products of triphala appeared to be the results of mixing T. chebula, T. bellerica, and E. officinalis. Further experimental analysis and data mining are required to specifically understand the mixing ratio. Waters, UPLC, ACQUITY UPLC, and Xevo are registered trademarks of Waters Corporation. The Science of What s Possible, MarkerLynx, and MassFragment are trademarks of Waters Corporation. All other trademarks are the property of their respective owners. 2011 Waters Corporation. Produced in the U.S.A. August 2011 720004050en AG-PDF Waters Corporation 34 Maple Street Milford, MA 01757 U.S.A. T: 1 508 478 2000 F: 1 508 872 1990 www.waters.com